Novartis AG (NVS)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 03:51PM EDT. Market open.
| Previous close | 99.06 |
| Open | 97.76 |
| Bid | 97.63 x 800 |
| Ask | 97.64 x 800 |
| Day's range | 97.56 - 98.22 |
| 52-week range | 92.19 - 108.78 |
| Volume | |
| Avg. volume | 1,627,775 |
| Market cap | 199.065B |
| Beta (5Y monthly) | 0.47 |
| PE ratio (TTM) | 22.17 |
| EPS (TTM) | 4.40 |
| Earnings date | N/A |
| Forward dividend & yield | 3.78 (3.81%) |
| Ex-dividend date | 07 Mar 2024 |
| 1y target est | 114.51 |
ZacksPharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
Investor's Business DailyWhy Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Novartis paved the way for radiopharmaceuticals. Now, Big Pharma thinks it can do better — and biotech stocks have soared on a spate of deals.
Insider MonkeyNovartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript April 23, 2024 Novartis AG isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and good afternoon, and welcome to the Novartis Q1 2024 Results Release Conference Call and Live Webcast. […]
© 2024 Yahoo. All rights reserved.